Refurbished Medical Devices Market (2026 - 2035)

Refurbished Medical Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Imaging Equipment, Surgical Instruments, Patient Monitoring Devices, Therapeutic Equipment), By End Users (Hospitals, Diagnostic Centers, Clinics, Research Institutions), By Product Condition (Like New, Refurbished, Used), By Applications (Cardiology, Orthopedics, Neurology, General Surgery) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
ID: MRFR/MED/0774-HCR
80 Pages
Nidhi Mandole, Rahul Gotadki
Last Updated: July 03, 2026
Refurbished Medical Devices Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)9.15%
2025 Market SizeUSD 17.67 Billion
2035 Market SizeUSD 42.43 Billion
Key Players
GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Hitachi Healthcare Americas
Stryker Corporation
Opportunities
  • Refurbishment-as-a-Service and Subscription Models
  • Digital Marketplace and AI-Driven Equipment Grading
  • Emerging-Market Hospital Build-Out Programs

Refurbished Medical Devices Market Summary

The Refurbished Medical Devices Market size was valued at USD 17.67 Billion in 2025, and the market is projected to grow from USD 19.29 Billion in 2026 to USD 42.43 Billion by 2035, registering a CAGR of 9.15% during the forecast period 2026–2035. Two catalysts are driving this trajectory: persistent hospital capital budget pressures that push procurement teams toward certified second-life equipment, and a wave of government green-procurement mandates — the EU Medical Device Regulation (MDR 2017/745) revision cycle and the U.S. FDA's expanded guidance on refurbishment standards — that legitimize the secondary equipment channel [1][2].

A generational technology refresh is underway across diagnostic imaging and surgical suites. Hospitals replacing analog X-ray and single-slice CT systems are finding that refurbished 64-slice CT scanners and 1.5T MRI units deliver 85–90% of new-unit performance at 40–55% lower acquisition cost. The World Health Organization estimated that low- and middle-income countries face a USD 40 billion annual deficit in medical device access, and refurbished channels are absorbing a growing share of that gap [3][4].

North America commands roughly 36.6% of the Refurbished Medical Devices Market, anchored by established OEM refurbishment programs from GE HealthCare and Siemens Healthineers. Asia-Pacific is the fastest-growing region at a 12.01% CAGR through 2035, propelled by India's Ayushman Bharat hospital modernization initiative and China's county-hospital equipment upgrade cycle. Europe holds the second-largest position with a 27.4% share, reinforced by NHS procurement frameworks that actively score sustainability credentials. As digital auction platforms and AI-driven equipment grading mature, the Refurbished Medical Devices Market is poised to evolve from a cost-saving alternative into a mainstream procurement channel.

 

Key Report Takeaways

• By Product Category

  • Medical imaging equipment held 36.6% of the Refurbished Medical Devices Market in 2025, reflecting steady demand for CT, MRI, and ultrasound systems across hospital networks.
  • Operating room and surgical equipment is forecast to expand at a 12.56% CAGR through 2035, driven by ambulatory surgical center build-outs in emerging economies.

• By Refurbishment Provider

  • OEM-certified channels accounted for a 59.3% share of the Refurbished Medical Devices Market in 2025, benefiting from brand trust and integrated service contracts.
  • Independent and in-house refurbishers are growing at an 11.39% CAGR, targeting underserved geographies with faster turnaround times.

• By End User

  • Hospitals represented USD 10.34 billion of the Refurbished Medical Devices Market in 2025, underscoring their role as the primary demand anchor.
  • Ambulatory surgical centers are advancing at a 12.24% CAGR through 2035, as outpatient procedure volumes shift outside traditional hospital walls.

• By Region

  • North America commanded 36.6% of the Refurbished Medical Devices Market in 2025, led by mature OEM programs in the United States.
  • Asia-Pacific is projected to post the fastest 12.01% CAGR between 2026 and 2035, fueled by government-backed hospital infrastructure investments.

 

Market Size and Forecast (2021–2035)

Market Research Future's sizing methodology integrates bottom-up revenue analysis from OEM refurbishment divisions, independent refurbisher financials, customs trade data on second-hand medical equipment, and validated hospital procurement surveys across 42 countries. Historical data (2021–2024) reflects audited company filings and WHO medical device trade databases, while the forecast period (2026–2035) applies econometric modeling calibrated against healthcare capital expenditure projections.

Refurbished Medical Devices Market Size and Forecast
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Driver Impact Analysis

Driver ~% Impact on CAGR Geographic Relevance Impact Timeline
Hospital budget constraints and cost-reduction mandates +2.1% Global Short-term (≤2 yr)
Government green-procurement and circular-economy policies +1.6% Europe, North America Medium-term (2–4 yr)
Expansion of private diagnostic centers in emerging markets +1.8% Asia-Pacific, Latin America Medium-term (2–4 yr)
AI-ready imaging upgrade cycle driving trade-in volumes +1.4% North America, Europe Long-term (≥4 yr)
Digital marketplace and auction platform maturation +1.1% Global Medium-term (2–4 yr)
Regulatory harmonization of refurbishment standards +0.9% Global Long-term (≥4 yr)
Ambulatory surgical center proliferation +0.8% North America, Asia-Pacific Short-term (≤2 yr)

 

Hospital Budget Constraints and Capital Reallocation

Growing operating costs are a problem for healthcare systems around the world. According to the American Hospital Association, hospital spending in the United States increased by 17.5% between 2019 and 2024, but reimbursement growth was just 8.2% [1]. Capital equipment committees are forced to choose reconditioned options as a result of this margin compression. 68% of U.S. hospital CFOs actively explored refurbished imaging equipment for at least one capital request during the previous fiscal year, according to a 2024 ECRI Institute survey. Because certified refurbished CT and MRI machines usually offer 40–55% savings over new-unit list prices without sacrificing diagnostic accuracy, the refurbished medical devices market immediately benefits from this structural change.

 

Circular-Economy Procurement Mandates

By 2030, 50% of medical equipment purchased by the public sector must be recycled or remanufactured, according to the European Commission's Circular Economy Action Plan [2]. In the UK, a number of NHS trusts have already integrated sustainability scoring into their procurement processes, giving circular economy attributes up to 15% of the evaluation weight. These legislative signals legitimate the market for refurbished medical devices as part of institutional ESG goals and establish a structural floor for demand for refurbished devices throughout European hospital networks.

 

Emerging-Market Diagnostic Center Expansion

India's Ayushman Bharat Digital Mission allocated INR 22,000 crore (approximately USD 2.6 billion) to upgrade diagnostic infrastructure in 150,000 health and wellness centers through 2028 [3]. Private diagnostic chains such as Metropolis Healthcare and Dr. Lal PathLabs are sourcing refurbished CT, ultrasound, and hematology analyzers to accelerate clinic roll-outs at 35–40% lower capital intensity. A parallel dynamic is playing out in Brazil, where SUS (Sistema Único de Saúde) modernization grants are funneling equipment budgets toward certified refurbished units to stretch limited federal allocations.

AI-Ready Imaging Upgrade Cycle

Hospitals investing in AI-assisted radiology workflows often discover that their existing imaging platforms lack the DICOM throughput, GPU integration, or software compatibility required to run AI inference at the scanner edge. GE HealthCare's Edison platform and Siemens Healthineers' AI-Rad Companion both require minimum hardware tiers that exclude pre-2018 scanner vintages [5]. This triggers a cascading equipment refresh: hospitals acquire AI-compatible new systems while trading in older — but still clinically serviceable — units to OEM refurbishment programs, expanding the Refurbished Medical Devices Market supply pipeline.

 

Restraints Impact Analysis

Restraint ~% Impact on CAGR Geographic Relevance Impact Timeline
Regulatory ambiguity on refurbishment vs. remanufacturing classification –1.2% Global Medium-term (2–4 yr)
Perception and trust barriers among clinicians –0.9% Emerging markets Short-term (≤2 yr)
Limited availability of spare parts for legacy devices –0.7% Global Long-term (≥4 yr)
Cybersecurity vulnerabilities in older connected equipment –0.6% North America, Europe Medium-term (2–4 yr)
OEM channel conflict and restrictive service agreements –0.5% North America Short-term (≤2 yr)

 

Regulatory Classification Uncertainty

Different jurisdictions continue to define "refurbishment" and "remanufacturing" differently. According to the U.S. FDA's 2024 draft advice, any alteration that modifies a device's intended performance specifications will cause it to be reclassified as remanufactured, necessitating a new 510(k) filing [9]. This uncertainty can cause a 6–12 month delay in time-to-market for each device category and raise compliance expenses for independent refurbishers. The market for refurbished medical devices is subject to uneven regulatory friction that benefits OEM-certified channels until uniform global criteria are established.

 

Clinician Trust and Perception Gaps

41% of imaging technologists in Southeast Asia voiced doubts about the dependability of refurbished MRI and CT equipment in a 2024 study conducted by the International Society of Radiographers, citing issues with software currency and image quality degradation [10]. Despite strong cost economics, institutional adoption is slowed by these perception hurdles, which are particularly severe in regions where refurbished equipment has a proven track record. Over time, this restriction can be lessened via educational initiatives and open equipment grading.

 

Spare Parts Scarcity for Legacy Platforms

As OEMs discontinue support for older scanner generations — Philips ended parts supply for its Achieva 1.5T MRI platform in 2023 — independent refurbishers face growing difficulty sourcing critical components such as gradient coils, X-ray tubes, and detector arrays [11]. This attrition gradually shrinks the addressable pool of refurbishable units and pressures margins for refurbishers specializing in legacy modalities.

 

Refurbished Medical Devices Market Opportunities

Refurbishment-as-a-Service and Subscription Models

Equipment-as-a-service contracts that bundle refurbished devices with maintenance, software updates, and eventual take-back are gaining traction among mid-size hospital groups unable to justify large capital outlays. GE HealthCare's SIGNA Care program and Siemens Healthineers' Smart Equipment Management offer blueprints for recurring-revenue models that reduce customer acquisition costs by 25–30% compared with outright sales. The Refurbished Medical Devices Market stands to capture a growing share of operational expenditure budgets as healthcare financing shifts from CapEx to OpEx.

Digital Marketplace and AI-Driven Equipment Grading

Online platforms such as DOTmed and MedWOW are evolving from classified-listing sites into transactional marketplaces with integrated inspection, logistics, and payment services. AI-powered grading algorithms that assess equipment condition from sensor telemetry and maintenance logs can reduce buyer uncertainty and compress sales cycles from months to weeks [6]. This liquidity improvement benefits the Refurbished Medical Devices Market by connecting supply and demand across geographies that previously lacked transparent secondary-market infrastructure.

Emerging-Market Hospital Build-Out Programs

Sub-Saharan Africa's hospital bed density remains below 1.5 per 1,000 population in 28 countries, according to WHO data [14]. Government-backed hospital construction programs in Kenya, Nigeria, and Ethiopia are allocating equipment budgets that blend new critical-care systems with refurbished imaging and laboratory devices to maximize facility coverage. The African Development Bank's USD 3 billion Health Infrastructure Investment Platform creates a dedicated funding channel for medical device procurement that explicitly includes certified refurbished equipment.

Surgical Robotics Entering the Refurbishment Cycle

First-generation da Vinci Si surgical systems are reaching their 8–10-year replacement window, creating a new equipment class for the refurbished channel. Intuitive Surgical's certified pre-owned program processed over 200 system placements in 2024 [15]. As robotic-assisted surgery penetration expands beyond academic medical centers into community hospitals, the Refurbished Medical Devices Market gains a high-value product category that commands refurbished price points of USD 600,000–900,000 per unit.

Data Monetization Through Equipment Lifecycle Analytics

Refurbishers that capture granular maintenance histories, usage telemetry, and failure-mode data from processed units can license these datasets to OEMs for product development and to insurers for equipment risk scoring. This data-monetization layer transforms refurbishment from a margin-thin trading business into a platform with recurring analytics revenue.

 

Refurbished Medical Devices Market Future Outlook

AI-Integrated Diagnostics and Smart Refurbishment

By 2030, AI-assisted diagnostic imaging is expected to represent over 45% of new radiology installations globally, according to Signify Research [20]. This creates a two-speed Refurbished Medical Devices Market: AI-compatible platforms command premium refurbished pricing, while legacy non-AI systems migrate toward price-sensitive emerging markets. Refurbishers that can retrofit AI software stacks onto existing hardware will capture a differentiated value tier.

Platform Economics and Marketplace Consolidation

Digital platforms for secondary medical equipment are consolidating — DOTmed processed over USD 1.2 billion in transaction volume in 2024 — and the next phase involves integrated logistics, financing, and equipment-grading services [6]. Platform economics will compress margins for small independent refurbishers while rewarding scale operators that can offer end-to-end procurement experiences for the Refurbished Medical Devices Market.

Sustainability Reporting and ESG Integration

Mandatory ESG disclosures under the EU's Corporate Sustainability Reporting Directive (CSRD) will require hospitals to quantify Scope 3 emissions from equipment procurement starting in 2026 [21]. Refurbished medical devices carry a 60–70% lower carbon footprint than newly manufactured equivalents, according to lifecycle analysis published by the Ellen MacArthur Foundation. This regulatory tailwind structurally advantages the Refurbished Medical Devices Market in European and increasingly in North American procurement decisions.

Surgical Robotics and High-Value Equipment Entering the Secondary Channel

The installed base of surgical robotic systems is projected to exceed 12,000 units globally by 2028, up from approximately 8,400 in 2025 [15]. As first-generation systems reach end-of-primary-life, the Refurbished Medical Devices Market gains access to a product category with unit economics five to eight times higher than conventional imaging. Certified pre-owned robotic systems will democratize access to robotic-assisted surgery for community hospitals that cannot justify USD 1.5–2.0 million new-system acquisitions.

 

Refurbished Medical Devices Market Segmentation

By Product Category

Segment Key Metric Primary Demand Driver
Medical Imaging Equipment (X-Ray, CT, MRI, Ultrasound) 36.6% share (2025) Diagnostic volume growth and AI upgrade trade-ins
Operating Room & Surgical Equipment (Anesthesia, Electrosurgical) 12.56% CAGR (2026–2035) ASC proliferation in emerging markets
Patient Monitoring & Life Support Equipment USD 2.48 Billion (2025) ICU capacity expansion post-pandemic
Cardiology & Cardiovascular Devices 9.82% CAGR (2026–2035) Rising cardiovascular disease prevalence
Laboratory & Diagnostic Equipment 8.4% share (2025) Private diagnostic chain roll-outs
Other Medical Devices USD 1.07 Billion (2025) Diversified end-use demand

 

Medical imaging equipment remains the largest product segment within the Refurbished Medical Devices Market, accounting for 36.6% of total revenue in 2025. CT scanners and MRI systems dominate this category because their high new-unit costs (USD 1.0–3.5 million for MRI) make refurbished alternatives — typically priced at 40–55% discounts — particularly attractive to mid-size hospitals and diagnostic centers. The AI-driven imaging upgrade cycle is accelerating trade-in volumes, expanding the refurbishable supply pipeline.

Operating room and surgical equipment is the fastest-growing product segment at a 12.56% CAGR. Ambulatory surgical centers in India, Brazil, and Southeast Asia are driving demand for refurbished anesthesia machines, electrosurgical units, and OR tables as they scale outpatient procedure volumes while managing capital constraints.

By Refurbishment Provider

Segment Key Metric Primary Demand Driver
OEM-Certified Refurbishers 59.3% share (2025) Brand trust, integrated service contracts
Independent Refurbishers 11.39% CAGR (2026–2035) Geographic reach, price competitiveness
In-House Hospital Refurbishment Programs USD 1.24 Billion (2025) Large health systems internalizing maintenance

 

OEM-certified refurbishers dominate the Refurbished Medical Devices Market with a 59.3% share in 2025, as hospitals and procurement organizations value the warranty assurance, genuine replacement parts, and software currency that OEM programs provide. GE HealthCare's GoldSeal, Siemens Healthineers' Proven Excellence, and Philips' Diamond Select programs set the benchmark for certified refurbishment quality.

Independent refurbishers are closing the gap, growing at an 11.39% CAGR by targeting underserved geographies where OEM service networks have limited reach. Companies such as Soma Technology and Block Imaging compete on faster turnaround times and willingness to work with legacy platforms that OEMs have discontinued.

By End User

Segment Key Metric Primary Demand Driver
Hospitals USD 10.34 Billion (2025) Capital budget optimization
Ambulatory Surgical Centers 12.24% CAGR (2026–2035) Outpatient procedure volume growth
Independent Diagnostic Centers 10.47% CAGR (2026–2035) Private diagnostic chain expansion
Research & Academic Institutions 5.8% share (2025) Grant-funded equipment procurement
Others (Clinics, Nursing Facilities) USD 0.89 Billion (2025) Primary care infrastructure build-out

 

Hospitals account for the largest end-user share of the Refurbished Medical Devices Market at USD 10.34 billion in 2025. Public hospital systems in both developed and developing markets rely on refurbished equipment to maintain diagnostic capacity without exceeding capital expenditure ceilings. Ambulatory surgical centers represent the fastest-growing end-user segment, reflecting the global shift toward outpatient delivery models and the capital-light expansion strategies these facilities employ.

 

Regional Market Share Analysis

Region Key Metric Primary Investment Themes
North America 36.6% share (2025) OEM refurbishment programs, ASC expansion
Europe USD 4.84 Billion (2025) Circular-economy mandates, NHS sustainability scoring
Asia-Pacific 12.01% CAGR (2026–2035) Government hospital modernization, private diagnostic chains
South America 7.1% share (2025) SUS equipment grants, PPP hospital construction
Middle East & Africa USD 1.08 Billion (2025) Development bank-funded health infrastructure
Total USD 17.67 Billion (2025)

The Refurbished Medical Devices Market follows a regional hierarchy shaped by healthcare spending maturity, regulatory frameworks for second-life equipment, and diagnostic infrastructure gaps.

 

North America

Country Key Metric Key Driver
United States 78.4% of regional share Largest OEM refurbishment base; GPO contract penetration
Canada 11.73% CAGR (2026–2035) Provincial health authority green-procurement mandates
Mexico USD 0.64 Billion (2025) IMSS hospital equipment replacement cycles

 

The United States anchors the Refurbished Medical Devices Market in North America through a mature ecosystem of OEM refurbishment facilities — GE HealthCare operates a 145,000-sq-ft refurbishment center in Milwaukee, and Siemens Healthineers processes over 4,000 units annually in Hoffman Estates, Illinois [16]. Group purchasing organizations such as Vizient and Premier negotiate refurbished equipment tiers into their contract portfolios, giving member hospitals structured access to certified units with standardized warranty terms. Canada's provincial health authorities increasingly embed sustainability criteria into equipment tenders, accelerating refurbished adoption in imaging departments.

Europe

Country Key Metric Key Driver
Germany 24.1% of regional share Strong OEM refurbishment base (Siemens, Dräger)
United Kingdom 10.84% CAGR (2026–2035) NHS sustainability roadmap and procurement scoring
France USD 0.72 Billion (2025) AP-HP centralized procurement of refurbished imaging
Italy 11.2% of regional share SSN cost-reduction directives
Spain 8.7% of regional share Regional health authority budget constraints
Nordic Countries 10.62% CAGR (2026–2035) Circular-economy leadership and green public procurement
Russia USD 0.31 Billion (2025) Import substitution policies favoring local refurbishers
Rest of Europe 14.8% of regional share Mixed regulatory maturity

 

Europe's Refurbished Medical Devices Market benefits from the EU's Circular Economy Action Plan and the growing weight of sustainability criteria in public hospital procurement. Germany serves as the continent's refurbishment hub, with Siemens Healthineers and Dräger operating dedicated facilities that process imaging, anesthesia, and patient monitoring equipment for redistribution across EU member states [2]. The UK's NHS has pledged to reach net-zero emissions by 2040, and refurbished medical equipment contributes to Scope 3 emission reductions in procurement — trusts that demonstrate circular purchasing receive favorable commissioning scores.

Asia-Pacific

Country Key Metric Key Driver
China 31.5% of regional share County-hospital equipment upgrade mandates
India 13.14% CAGR (2026–2035) Ayushman Bharat diagnostic infrastructure expansion
Japan USD 0.58 Billion (2025) Aging population driving imaging volume growth
South Korea 9.8% of regional share MOHW cost-containment in tertiary hospitals
ASEAN 12.47% CAGR (2026–2035) Thailand and Vietnam hospital construction pipelines
Rest of Asia-Pacific 8.4% of regional share Mixed market maturity

 

Asia-Pacific represents the fastest-growing frontier for the Refurbished Medical Devices Market. China's State Council directive to equip 1,500 county-level hospitals with advanced diagnostic imaging by 2027 explicitly permits procurement of certified refurbished CT and MRI systems to stretch provincial budgets [17]. India's private diagnostic sector is expanding at over 15% annually, and chains such as SRL Diagnostics routinely source refurbished hematology analyzers and ultrasound units to maintain capital discipline during rapid geographic roll-outs.

South America

Country Key Metric Key Driver
Brazil 62.3% of regional share SUS modernization grants for public hospitals
Argentina 10.28% CAGR (2026–2035) Currency constraints favoring refurbished imports
Rest of South America USD 0.28 Billion (2025) Emerging private clinic networks

 

Brazil dominates South America's Refurbished Medical Devices Market, supported by SUS equipment grants that allow public hospitals to procure certified refurbished imaging and surgical devices. Currency volatility in Argentina and Colombia makes new-equipment imports prohibitively expensive, creating a natural price advantage for refurbished alternatives sourced through Miami- and São Paulo-based redistribution hubs [18].

Middle East & Africa

Country Key Metric Key Driver
Saudi Arabia 28.7% of regional share Vision 2030 healthcare infrastructure expansion
UAE 10.91% CAGR (2026–2035) Medical tourism driving diagnostic capacity investment
South Africa USD 0.19 Billion (2025) NHI pilot procurement of refurbished equipment
Egypt 14.3% of regional share Population growth straining public hospital capacity
Rest of MEA 9.78% CAGR (2026–2035) AfDB health infrastructure lending programs

 

The Middle East & Africa's Refurbished Medical Devices Market is shaped by two distinct dynamics: Gulf Cooperation Council states investing in premium healthcare to support medical tourism strategies, and Sub-Saharan African nations leveraging development finance to close diagnostic access gaps. Saudi Arabia's Vision 2030 is building 44 new hospitals, and procurement guidelines allow up to 30% of imaging equipment budgets to be allocated toward certified refurbished systems [19].

 

Refurbished Medical Devices Market By Region, 2025-2035

Competitive Benchmarking

The Refurbished Medical Devices Market exhibits medium concentration. The top five players — led by GE HealthCare, Siemens Healthineers, and Philips — collectively control an estimated 42–48% of global revenue. OEM refurbishers leverage brand recognition, parts access, and integrated service networks as competitive moats, while independent refurbishers compete on price agility, geographic coverage, and modality specialization. The Herfindahl-Hirschman Index (HHI) sits in the 800–1,100 range, indicating a moderately competitive landscape with meaningful room for specialist players.

Company Est. Revenue Share Range Key Offerings Strategic Positioning
GE HealthCare ~12–15% GoldSeal certified CT, MRI, ultrasound, patient monitoring Largest OEM refurbishment network; integrated financing solutions
Siemens Healthineers ~10–13% Proven Excellence imaging, laboratory diagnostics European refurbishment hub; AI-compatible upgrade pathways
Philips Healthcare ~8–11% Diamond Select MRI, CT, patient monitoring Strong in cardiac imaging refurbishment; subscription models
Canon Medical Systems ~4–6% Certified pre-owned CT, MRI, ultrasound Competitive pricing in APAC markets
Hitachi Healthcare Americas ~3–5% Refurbished open-bore MRI, ultrasound Niche focus on open MRI for claustrophobic patients
Stryker Corporation ~3–5% Certified pre-owned surgical navigation, endoscopy Surgical equipment specialization; strong ASC relationships
Soma Technology Inc. ~2–4% Multi-vendor refurbished patient monitoring, anesthesia Independent leader; fast turnaround for legacy platforms
US Med-Equip ~2–3% Rental and refurbished patient monitoring, beds, infusion Rental-to-purchase model; strong U.S. hospital penetration
Block Imaging International ~2–3% Independent MRI, CT, X-ray refurbishment Parts sourcing network; training and field service
Avante Health Solutions ~1–3% Refurbished surgical, imaging, and sterilization equipment Broad portfolio across operating room modalities

 

 

Recent News & Developments

  • April 2025: Master Medical Equipment announced that it has joined the Health Industry Distributors Association (HIDA), a strategic alliance intended to bolster their position in the market for reconditioned medical devices and reinforce their dedication to healthcare distribution excellence.
  • January 2025: According to Henry Schein, KKR made a strategic investment of USD 250 million, acquiring a 12% share in the business to promote strategic expansion and operational excellence in healthcare services and distribution.
  • April 2024: regional councils and IBEM met with ANVISA, Brazil's health regulatory body, to consider including industrial technicians in the regulation of refurbished medical devices. This step might increase Brazil's capacity for refurbishing while upholding quality standards.

 

 

 

 

 

 

 

 

 

Refurbished Medical Devices Market Report Scope

Parameter Detail
Market Scope Global Refurbished Medical Devices Market across product categories, refurbishment providers, end users, and five geographic regions
Study Period 2021–2035
CAGR (Forecast) 9.15% (2026–2035)
Market Size (2025) USD 17.67 Billion
Market Size (2035) USD 42.43 Billion
Fastest Growing Segment Operating Room & Surgical Equipment (12.56% CAGR); Ambulatory Surgical Centers (12.24% CAGR)
Companies Profiled 10 (GE HealthCare, Siemens Healthineers, Philips, Canon Medical, Hitachi, Stryker, Soma Technology, US Med-Equip, Block Imaging, Avante Health Solutions)
Valuation Currency USD Billion

 

 

FAQs

What equipment grading system should buyers use when comparing refurbished medical devices from multiple vendors?
Request Grade A (cosmetically and functionally restored to OEM specifications) and verify the unit includes updated software, calibration certificates, and a minimum 12-month parts-and-labor warranty [4].
How do financing structures differ for refurbished versus new medical equipment purchases?
Refurbished units qualify for shorter lease terms (36–48 months versus 60–84 months for new), which lowers total cost of ownership but requires higher monthly payments. Equipment-as-a-service contracts are emerging as a flexible alternative [6].
What due-diligence steps should a procurement team take to evaluate an independent refurbisher's quality management?
Confirm the refurbisher holds ISO 13485 certification, request documented component replacement logs, and verify that post-refurbishment testing protocols align with the OEM's factory acceptance criteria [13].
Which imaging modalities retain the highest residual value on the secondary market?
MRI systems retain 35–45% of original list price after 7–8 years, outperforming CT scanners (25–35%) and general X-ray systems (15–20%) due to longer clinical relevance and higher replacement costs [6].
How are cybersecurity risks managed in refurbished connected medical devices?
Reputable refurbishers patch operating systems, update firmware, and remove prior-owner data before resale. Buyers should mandate IEC 62443 compliance documentation and network segmentation protocols at installation [12].
What role do trade-in programs play in the competitive dynamics of the Refurbished Medical Devices Market?
OEM trade-in programs secure a steady pipeline of refurbishable inventory while locking customers into upgrade cycles. Independent refurbishers counter by offering higher trade-in valuations and vendor-agnostic support [13].
How does the refurbished surgical robotics segment differ from conventional refurbished imaging in terms of buyer considerations?
Surgical robotic systems require instrument compatibility verification, software licensing transfers, and surgeon-training recertification — steps unnecessary for imaging equipment. These added layers increase lead times by 8–12 weeks [15].    
What is the current size of the refurbished medical devices market?
The refurbished medical devices market reached USD 17.67 billion in 2025 and is projected to reach USD 42.43 billion by 2035.
What is the CAGR of the refurbished medical devices market?
The refurbished medical devices market is projected to grow at a CAGR of 9.15% during the forecast period 2026–2035.
Which region leads the refurbished medical devices market?
North America holds the largest share at 36.6%, while Asia-Pacific is the fastest-growing region at 12.01% CAGR.
Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, international standards publications, peer-reviewed clinical engineering journals, and authoritative health technology management sources. Key sources included the US Food & Drug Administration (FDA) Remanufacturing Guidance, European Medicines Agency (EMA) Medical Device Regulation (EU) 2017/745 Article 17 implementation reports, Health Canada Medical Devices Regulations (SOR/98-282), Association for the Advancement of Medical Instrumentation (AAMI.org) standards including ANSI/AAMI EQ56:2024, Medical Imaging & Technology Alliance (MITA/NEMA) Standard 1-2015 for Good Refurbishment Practices, International Electrotechnical Commission (IEC 63077:2019) on refurbishment of medical imaging equipment, International Organization for Standardization (ISO 13485:2016) for quality management systems, World Health Organization (WHO) Global Model Regulatory Framework for Medical Devices, National Center for Biotechnology Information (NCBI/PubMed) for clinical safety studies, Radiological Society of North America (RSNA) proceedings, Association for Medical Imaging Management (AHRA) capital equipment surveys, OECD Health Statistics, EU Eurostat Healthcare Equipment databases, and national health ministry reports from key markets including FDA Center for Devices and Radiological Health (CDRH) Establishment Registration databases. These sources were used to collect refurbishment workflow statistics, regulatory compliance data, equipment lifecycle studies, safety incident reports, and market landscape analysis for medical imaging equipment (MRI, CT, ultrasound, X-ray, nuclear imaging), operating room equipment, patient monitoring devices, and cardiology/neurology systems.

 

Primary Research

To gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. In addition to independent refurbishers and large-scale independent service organizations (ISOs) that specialize in secondary market medical equipment, supply-side sources included presidents, vice presidents of refurbishment operations, regulatory affairs heads, directors of quality assurance, and commercial directors from original equipment manufacturers (OEMs) with certified refurbishment programs (GE HealthCare GoldSeal, Siemens Healthineers refurbished systems, Philips DiamondSelect). Chief procurement officers, directors of clinical engineering, heads of radiology departments, managers of biomedical equipment, and capital budgeting leads from academic medical centers, ambulatory surgical centers, diagnostic imaging centers, integrated health networks, and group purchasing organizations (GPOs) were among the demand-side sources. Primary research verified equipment pipeline timelines for AI-enabled refurbished imaging systems, validated market segmentation by type of refurbishment provider (OEM-certified vs. independent), and collected information on clinical adoption trends, total cost of ownership analysis, maintenance contracting strategies, and regulatory compliance dynamics across jurisdictions.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Global market valuation was derived through revenue mapping and installed base analysis. The methodology included:

Identification of 55+ key manufacturers, OEM-certified refurbishment divisions, and independent refurbishers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Product mapping across medical imaging equipment (MRI, CT scanners, ultrasound, X-ray, nuclear medicine/PET-CT), operating room & surgical equipment (anesthesia machines, electrosurgical units, surgical microscopes), patient monitoring devices, cardiovascular equipment, neurology systems, and endoscopy devices

Analysis of reported and modeled annual revenues specific to refurbished/refurbishment service portfolios, including trade-in cycles and remarketing revenues

Coverage of OEM refurbishment programs and major independent refurbishers representing 72-76% of global market share in 2024

Extrapolation using bottom-up (installed base decommissioning rates × refurbishment conversion rates × ASP by modality and country) and top-down (manufacturer/refurbisher revenue validation) approaches to derive segment-specific valuations and regional market sizes

Incorporation of equipment age analytics (7-12 year primary lifecycle extension data) and hospital capital expenditure budget allocation trends for pre-owned medical technology

Data Triangulation & Validation

Market estimates were triangulated through:

Cross-referencing primary interview insights against secondary regulatory filing data and industry association statistics

Validation of average selling price (ASP) data across OEM-certified refurbishment programs and independent third-party refurbishers

Calibration against reported hospital procurement budgets for diagnostic imaging equipment and capital equipment lifecycle management surveys

Verification of refurbishment volume estimates against IEC 63077 certification database trends and notified body conformity assessment volumes under EU MDR Article 17

Quality assurance through multi-source confirmation of market sizing variables including equipment deinstallation forecasts, parts availability indices, and secondary market trade flows

FDA Final Guidance on "Remanufacturing of Medical Devices" (May 2024) distinguishing remanufacturing from servicing activities

EU MDR (EU) 2017/745 Article 17 and Common Specifications for reprocessing of single-use devices; European Commission Implementation Reports (2024)

Health Canada Medical Devices Regulations (SOR/98-282) provisions on refurbishment and resale of Class II-IV devices

AAMI EQ56:2024 Standard for Medical Equipment Management Programs and refurbishment quality systems

MITA NEMA 1-2015 Good Refurbishment Practices for Medical Imaging Equipment

IEC 63077:2019 Good refurbishment practices for medical imaging equipment

ISO 13485:2016 Medical devices — Quality management systems — Requirements for regulatory purposes

WHO Technical Report Series: Global Model Regulatory Framework for Medical Devices (including refurbishment provisions)

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.